Despite President Trump’s self-described rosy health status, physicians warn that he is still in a pivotal phase of the illness, The New York Times reports.
Information on his lung function, which would offer critical insights, hasn’t been released. However, his treatment regimen has included:
- Supplemental oxygen
- An experimental antibody cocktail, REGN-COV2
- The antiviral remdesivir, which can cause nausea and chills
- The common steroid dexamethasone, which can cause mental side effects including aggression and delirium, The Hill reports.
REGN-COV2 has been given to just 10 people outside of clinical trials, AP reports. Remdesivir and dexamethasone are typically reserved for seriously ill patients.
While his office may warrant Trump special treatment, “The question is whether it’s good treatment,” notes Boston University’s George Annas.
Receiving this combination of drugs so early in the course of a purportedly mild illness would makes him somewhat of a guinea pig—but to some public health experts, this all-in regimen suggests he may be sicker than his doctors suggest, NPR reports.
His VIP treatment—one that the average COVID-19 patient could only dream of—also raises ethical questions, AP reports.
“With so many people not even having access to the basics,” Trump’s special treatment is “a symptom of a much larger problem,” said Steven Joffe, medical ethics chief at the University of Pennsylvania.